Abu Dhabi sovereign wealth fund Mubadala will proceed with a restructuring of the Turkish Getir grocery delivery service which it bought a controlling stake in last year. “Getir shareholders ...

DiabTec’s facility includes 20,000-liter drug substance reactors and a separate cartridge fill-finish facility for drug products KELIX bio, wholly owned by Mubadala Investment Company (Mubadala), said ...

KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...

Getir founders allege Mubadala breached restructuring agreement Mubadala claims founders failed to complete June agreement Mubadala says it will present new plan to Getir shareholders in coming ...

KELIX Bio, a subsidiary of Mubadala Investment Company, has completed its acquisition of DiabTec, a biomanufacturing facility previously owned by Julphar, one of the UAE’s largest pharmaceutical ...

Getir’s founding team had previously clashed with investors, primarily Mubadala, over the company’s strategy and costs. Its valuation plunged to $2.5 billion in 2023 from its peak of $11.8 ...

plans to go private in a C$4.7 billion ($3.4 billion) deal backed by Mubadala Capital, one of the largest-ever privatizations by an Abu Dhabi entity in the financial sector. Shareholders of ...

(Bloomberg) -- Private credit has been the best-performing asset class for Mubadala Investment Co. for three years in a row, according to the Abu Dhabi sovereign wealth fund’s deputy group chief ...

Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens Mubadala's ...

UAE - Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens ...